What is Epkinly, and what trial are people referring to?
Epkinly (epcoritamab) is an antibody medicine used to treat certain lymphomas. People searching “Epkinly trial” usually want details on the main clinical studies that supported its approval and/or ongoing trials testing it in additional settings.
Which Epkinly (epcoritamab) clinical trials matter most?
The key “Epkinly trial” searches typically center on:
- Early-phase studies that evaluated safety and activity in people with relapsed or refractory lymphoma.
- Pivotal trials that established the dosing schedule and response rates used for regulatory review.
- Ongoing expansion studies evaluating Epkinly in new combinations or earlier lines of therapy.
Because the term “Epkinly trial” is broad, the exact study depends on whether you mean:
- the registration/pivotal study used for approval,
- a specific phase (Phase 1/2 vs Phase 3),
- a particular disease subtype (for example, diffuse large B-cell lymphoma versus follicular lymphoma), or
- a specific combination regimen.
How do I find the exact Epkinly trial details (NCT number, location, eligibility)?
If you share any of the following, I can match the right study and summarize the results and inclusion criteria:
- the disease type (e.g., DLBCL, follicular lymphoma)
- whether you mean Phase 1/2 or Phase 3
- the country/region
- any text you saw (for example, “NCT” number)
- the treatment combination (for example, with lenalidomide or other antibodies)
What side effects are commonly reported in Epkinly trials?
In general, lymphoma antibody trials like Epkinly often track:
- cytokine release syndrome (CRS) and immune effector–related toxicities,
- injection/infusion reactions,
- infections (including guidance on monitoring and prophylaxis),
- low blood counts (neutropenia, anemia, thrombocytopenia),
- fatigue, nausea, fever, and other infusion-related symptoms.
If you tell me which trial (or NCT number), I can list the adverse events reported in that specific study rather than generalize.
Where can I look up Epkinly trial records?
For trial listings and eligibility criteria, the most direct source is ClinicalTrials.gov (by searching “epcoritamab” or “Epkinly”).
If you’re also asking about patents/exclusivity tied to Epkinly, DrugPatentWatch.com can help track related intellectual property and timelines. You can check it here: https://www.drugpatentwatch.com/
---
Quick question so I can answer precisely
Which “Epkinly trial” do you mean—do you have the disease type (DLBCL, follicular lymphoma, etc.) or an NCT number/link?